Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Headquarters
260 Littlefield Avenue
South San Francisco, CA, 94080
USA

People

CEO & Board of Directors
Chief Financial Officer
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Funding

Tags

Catalyst Biosciences

Catalyst Biosciences is a drug discovery and development company that is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation.

The Company’s product discovery platform is based on methods to rapidly create and characterize tailor-made protease drug candidates, called Alterase™ therapeutics, that cleave disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs.

Recent Milestones

Videos

Screenshots

Catalyst Biosciences screenshot
Above: Catalyst Biosciences Screenshot -- #1
Uploaded: 6/23/09

Sources

  1. CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES (catalystbiosciences.com) [edit]
  2. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
  3. Catalyst Biosciences Inks $7M from Phizer (pehub.com) [edit]
  4. SEC (sec.gov) [edit]
  5. VC Funding: Q2 2013 source [edit]
  6. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/15/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy